LR-19128 PD-L1 XT

N/A

Report date: 2024/04/18 11:25:09

Base Information

Drug NameLR-19128 PD-L1 XT
Drug Alias NameLR-19128-PD-L-1-XTLR19128 PD-L1 XTLR-19128LR19128
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionProgrammed death-ligand 1 blockers
TargetsProgrammed death-ligand 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAvacta Life Sciences Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAvacta Life Sciences LtdLg Chemical Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A